NASDAQ · Biotechnology

TBPH (TBPH) Stock

$16.86 +0.06% NASDAQ: TBPH Healthcare

Valuation

MetricValue
Price$16.86
Market Cap$873.82M
P/E Ratio8.26
P/B Ratio2.95
P/S Ratio7.64
EPS (TTM)$2.06
52-Week High$21.03
52-Week Low$10.44
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE35.69%
ROA21.81%
ROCE-4.38%
Gross Margin-13.08%
Operating Margin-12.15%
Net Margin1.04%
Debt/Equity0.25
Current Ratio11.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$55.0M$51.0M$57.0M$64.0M$107.0M
Operating Profit$-258.0M$-92.0M$-56.0M$-47.0M$-13.0M
Net Profit$-199.0M$872.0M$-55.0M$-56.0M$106.0M
EPS$-2.87$-1.26$-1.00$-1.15$2.06
Op Margin-466.1%-179.1%-97.6%-72.9%-12.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$375.0M$607.0M$382.0M$354.0M$486.0M
Total Liabilities$713.0M$166.0M$169.0M$179.0M$189.0M
Cash$90.0M$298.0M$40.0M$38.0M$168.0M
Borrowings$670.0M$52.0M$49.0M$50.0M$75.0M

Latest News

Theravance Biopharma Insider Sold Shares Worth $5,791,555, According to a Recent SEC Filing MT Newswires · Jul 2, 2026 Zymeworks (ZYME) Stock Looks Fully Valued Despite Its 205% Three Year Run Simply Wall St. · Jul 1, 2026 Theravance Stock Down 3% After Zymeworks Announces Buyout Zacks · Jun 30, 2026 Zymeworks agrees to buy Theravance Biopharma for $929m Pharmaceutical Technology · Jun 30, 2026 Sector Update: Healthcare Stocks Higher Late Afternoon MT Newswires · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-208.0M$-187.0M$-27.0M$-12.0M$239.0M
Investing Cash Flow$121.0M$1.2B$-35.0M$12.0M$-105.0M
Financing Cash Flow$-6.0M$-127.0M$-199.0M$-3.0M$-4.0M
Net Cash Flow$8.0M$208.0M$-259.0M$-2.0M$130.0M
Free Cash Flow$-211.0M$-188.0M$-29.0M$-12.0M$238.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield32.06%
Quick Ratio13.14
Interest Coverage-6.50
Return 1Y49.20%
Return 3Y74.53%
Return 5Y24.23%

Ownership

Insiders Held4.68%
Institutions Held98.22%
Institutions Float Held103.05%
Institutional HolderSharesReport Date
Madison Avenue Partners, LP9,511,1502026-03-31
Weiss Asset Management Lp7,457,0602026-03-31
Newtyn Management, Llc4,841,6292026-03-31
Blackrock Inc.4,296,2902026-03-31
Irenic Capital Management LP 2,760,9482026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AVBP $30.84 -0.55% -8.82 $1.44B 0.00%
BTXBlackRock Innovation and Growth Term Trust $8.58 +2.02% 0.00 $1.00B 8.21%
DAWNDay One Biopharmaceuticals, Inc. $21.53 +0.00% -20.70 $2.22B 0.00%
GERN $1.34 -4.29% 23.17 $859.64M 0.00%
GLUE $22.56 -0.97% -40.87 $1.91B 0.00%

About TBPH

TBPH is led by CEO Rick E. Winningham, employs 97 people, headquartered in US, publicly traded since 2014.

TBPH stock trades at $16.86 with a market capitalization of $873.82M. The stock is valued at a price-to-earnings (P/E) ratio of 8.26, price-to-book of 2.95, price-to-sales of 7.64. Over the past 52 weeks the stock has ranged between $10.44 and $21.03, and currently trades 19.8% below its 52-week high.

On profitability, TBPH generates a return on equity (ROE) of 35.69% — well above the market average, a sign of a high-quality business, return on capital employed of -4.38%, an operating margin of -12.15%, a net profit margin of 1.04%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides